Therefore, our data indicate that sequencing the 5'UTR of CDKN2A should be included in routine screening of PC cases with suspected inherited susceptibility families and that the sequenced region should be extended from current set-up of sequencing to cover the entire 5’UTR region. This evidence concerns the gene CDKN2A and pachyonychia congenita.